24^th World Congress on Pediatric Oncology and Cancer Care October 02-03, 2023 Frankfurt, Germany

The "24th World Congress on Pediatric Oncology and Cancer Care" will take place in Frankfurt, Germany, from October 02-03, 2023 centered around the theme on Pediatric Cancer and Oncology: Improving Treatments and Fostering Supports. It will feature keynote speeches, poster presentations, oral lectures, and exhibitions. In order to discuss and learn more about various topics related to Cancer Biomarkers, Anti-Cancer drug discovery therapy, Gynaecologic Oncology, Immuno Oncology, Neuro Oncology, Oncology Nursing, Pediatric Oncology, Pulmonary Oncology, Surgical Oncology, Cancer and Oncology Genetics and further more. There is a worldwide platform known as the Pediatric Cancer Congress. At Pediatric Oncologists 2023, Conference Series has made the first move to bring together bright specialists from both industry and academia on a single platform.

Young researchers and students can observe the research on paediatric cancer that is presented at the conference from a variety of scientific backgrounds. The primary goal of Pediatric Cancer Congress 2023 is to disseminate knowledge in the medical and life sciences that researchers would need in the course of their work. As a result, Germany would be the ideal location for this exchange of information.

The Pediatric Cancer Congress 2023 provides a global forum for the presentation of research on cutting-edge methods, ground-breaking devices, and numerous recently introduced drugs for the treatment of paediatric and neonatal oncology. By exchanging ideas on various topics under this subject, the conference contributes to the dissemination of knowledge and lowers the incidence rate globally. Each conference frequently features several speakers, all of whom are experts in oncology-related subjects. Every day during the Pediatric Oncology Congress, a variety of topic analyses are scheduled, and participants often select their own topics from among these global events.

The goal of Pediatric Cancer Congress 2023 is to present honorary awards to deserving Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, and junior professors in recognition of their excellent contributions to the conference theme. The Young Scientist Awards strive to offer academicians in their early careers with a solid professional development opportunity by bringing specialists together to exchange and share their expertise on all facets of cancer care and oncology.

Young Researchers in Pediatric Cancer Congress Awards for the Nomination in 2023:

The Pediatric Cancer Congress 2023 Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation will only accept 20 presentations.

Advantages of YRF Registrations:

• Young Scientist Award recipients get certificates of achievement and souvenirs.
• For oral presentations of your research, Pediatric Cancer Congress 2023 offers the finest venue.
• Through networking, you can find out about new technology and employment opportunities.
• Permit research collaboration with renowned senior researchers from around the globe in the area of nanotechnology.
• It's a fantastic chance for young researchers to learn about different study fields and increase their research knowledge.

Abstract submission: December 15, 2022
First Phase Registration: January 1st, 2023
Second Phase Registration: 1st May, 2023

Book your slot: https://cancer.pediatricsconferences.com/registration.php

Group registration (Minimum 5 members) can avail 20% waivers from the registration fee.

Email: Program Manager at [email protected] or WhatsApp at (+44) 7362049945 with details of the 5 participants.

Thanks and Regards
Andre Sarria | Conference Executive
Pediatric Cancer Congress 2023

Abstract submission guidelines for Pediatric Cancer Congress conferences:

• If you choose to participate in this conference, you need to submit an abstract
• The abstract should carry the summary of a research
• Abstract should be submitted either through e-mail or using the link given below
• Abstracts should be based on any areas as listed in this website as sessions/tracks

Note: The review process for the submitted abstract will take 2-3 working days

Submitting abstract will be published in conference proceedings in the conference supporting journal

Abstract Submission website: https://cancer.pediatricsconferences.com/abstract-submission.php

For conference attendance, Just a business visa should be requested. Reach out to the Embassy in Germany or the closest travel agency for the relevant application form. All visas for travel to or via Frankfurt, Germany, must be handled by the appropriate authorities only when valid documentation has been submitted via the correct channels.

If documents are missing or rules are not followed, visas may be cancelled by the relevant authorities.
The bare minimum supporting documentation that can be needed when applying for a visa to Frankfurt, Germany, is as follows:

•  Letter of Invitation,
• Abstract acceptance letter (if speaker),
• Registration payment receipt,
• Letter of confirmation of accommodation was sent on the conference letterhead.

Send us an email at [email protected] with any questions.

Track 1: Proton therapy

Track 2: Pediatric Hematologic Malignancies

Track 3: Tumour Biology, Immunology and Immunotherapy

Track 4: Supportive Care and Palliative Care

Track 5: Epidemiology, Policy and Advocacy

Track 6: Rare tumours and Histiocytosis

Track 7: Myeloid leukaemia, Myelodysplastic and Myeloproliferative Syndrome

Track 8: Organic Foods and Cancer Risk: Separating Myth from Fact

Track 9: Oncology Nursing

Track 10: Radiation Oncology

Track 11: Colorectal Cancer and Stem Cells

Track 12: Cancer Causes and Diagnosis

Track 13: Cancer Biomarkers

Track 14: Cancer Therapeutics and Novel Approaches

Track 15: Cancer Management and preventions

Track 16: Gynaecologic Oncology

Track 17: Immuno Oncology

Track 18: Neuro Oncology

Track 19: Anticancer drug-discovery therapy

Track 20: Pediatric Oncology

Track 21: Pulmonary Oncology

Track 22: Surgical Oncology

Track 23: Cancer and Oncology Diagnosis and Screening

Track 24: Cancer and Oncology Genetics

Track 25: Cancer Awareness and Survival

Track 26: Cancer Epidemiology Prevention

Track 27: Cancer Metastasis

Track 28: Clinical Oncology

Track 29: Natural methods for treatment of Cancer

Track 30: Neonatal and Pediatric Oncology

Track 31: Oncology and Cancer Research

Track32: PediatricPharmacotherapy

Track 33: Breast Cancer

Pediatric Cancer Congress 2023 is one of the best and most exciting opportunities that have been created in an interdisciplinary approach with a wide range of tracks to present new technology, new goods, and services that your sector may provide to a big global audience. They will have a great opportunity to showcase their most recent work on Pediatric Cancer and Oncology because it covers a wide variety of themes.

It anticipates more than 200 attendees from around the world to participate with thought-provoking Keynote lectures, oral presentations, and poster presentations at Pediatric Cancer Congress 2023, which will feature presentations by professionals from around the world in the field of medical, healthcare and oncology fields. Editorial board members from related international publications are represented by the delegates.

As a low-cost marketing strategy for generating sales, possibilities, and contacts, business networking gives suppliers the chance to network and meet with "Top Scientists and Colleagues." To encourage students and recent graduates to exhibit their unique research, which will be published in journals later, the student poster competition is held at the conference.

Poster sessions at the conference will feature all of the submitted abstracts. Students who are unable to attend the conference can present an E-Poster for just $99, with the abstract being posted online with a DOI. The addition of live streaming is a value-added service for the speaker.

Target Audience:

Doctors, Young Research Scientists, Medical Colleges, Pediatric Cancer Associations and Societies, Manufacturing Medical Devices Companies, Healthcare Professionals, Directors of healthcare Companies, Leading Scientists, Oncologists, Medicine, and Pharmaceuticals, Fellows or Postdoctoral Students, Researchers, CEOs, and Business Delegates

Highlights of the conference:

• More than 300 participants (70 Industry: 30 Academia)
• Five keynote speakers or more; 50 or more speakers at the plenary; and Twenty exhibitors or more
• Five or more workshops; fourteen creative educational sessions; and business meetings

The pleasure of attending Pediatric Cancer Congress 2023 entails improvement and gradual evolution in your method of operation, as well as the opportunity to view things in a wider framework and encounter the educational and industrial overviews.

Partnering to implement the Global Initiative for Childhood Cancer in the Americas: prioritizing systems strengthening:

As a WHO Collaborating Centre for juvenile Cancer, St. Jude Children's Research Hospital (SJCRH) plays a crucial role in collaborating with PAHO/WHO to prioritize juvenile cancer in the context of system strengthening. The focus is to use C5 (Country Collaboration for Childhood Cancer Control) to define and carry out priority actions regionally, strengthening Ministry programs for childhood cancer while implementing the Global Initiative for Childhood Cancer since 2020. To map the needs of health systems and prioritize strategic initiatives (covering Central America, the Dominican Republic, Haiti, Brazil, and Uruguay), PAHO/WHO and SJCRH co-hosted regional/national workshops with participation from authorities, clinicians, and other stakeholders across 10 countries.

Cancer Disparities Research In 2023

According to Melissa B. Davis, PhD, who is an associate professor of cell and developmental biology research and the scientific director of the International Center  for the Study of Breast Cancer Subtypes at Weill Cornell Medical College, advances in immuno-oncology will likely dominate the field of cancer disparities research in the upcoming year. According to her, "We are beginning to elucidate the population-level variation in the tumor immune landscapes across various cancer types."

According to AACR, artificial intelligence is also taking on a more significant role. It will be used in imaging, histology, and diagnostics, as well as informatics data mining, which is related to the creation of algorithms to find the genetic factors that influence tumor biology.

Pediatric Cancer: Its Aspects and Relevance

The medical specialties are pediatrics which covers the medical care for children, teenagers, and newborns. Children's bodies are more sensitive to disease and infection than teens' bodies are. Surgery, chemotherapy, immunotherapy, radiation therapy, and germ/stem cell transplant are common forms of treatment. In order for new ideas or new research to be discussed at the conference and be helpful to children with cancer disorders, we anticipate the experienced global gathering at the neonatal and pediatric centres.

Market Overview

A compound annual growth rate (CAGR) of 7.8% is projected for the market for breast cancer medications worldwide, which will increase from $31.50 billion in 2022 to $33.96 billion in 2023. At least temporarily, the Russia-Ukraine conflict hampered the chances of the world's economy recovering from the COVID-19 epidemic. Due to supply chain interruptions, a rise in commodity prices, and economic sanctions against other nations as a result of the conflict between these two nations, many markets around the world are now experiencing inflation in goods and services. A CAGR of 6.8% is predicted for the market for breast cancer medications to reach $44.11 billion in 2027.

Market for Non-Small Cell Lung Cancer, According to cancer type (including non-small cell lung cancer, metastatic lung cancer, pulmonary neuroendocrine tumors, mediastinum tumors, mesothelioma, and chest wall tumors), molecule type (including small molecules and biologics), drug class (including alkylating agents, antimetabolites, EGFR inhibitors, mitotic inhibitors, multi-kinase inhibitors, and others), and treatment type (including chemotherapy, radiation therapy, and targeted therapy), Industry Trends and Forecast to 2030: End User (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online, and Others).

The term "childhood cancer" refers to cancers that affect children and young adults (those under the age of 15). Depending on the type and stage of the disease, there are numerous efficient cancer therapy options accessible today. Although the majority of cases of juvenile cancer are unknown, it is thought that hereditary mutations are responsible for 5% of all paediatric cancers.

The considerable advancement in the area of improvement highlighted by an onco diagnostic broadcast, the general risk diagnostics stage will quickly bring about a change. These tests on new or old drugs to the development of a new generation of clinical trials to treat disease and lessen the toxicity. The various strategies to prevent and remediate cancer harm will emerge and mature at a great pace.

The primary factors driving the growth of the pediatric oncology market's revenue are the rise in childhood obesity globally, the prevalence of childhood cancer, the increase in public awareness of cancer therapies, and increased R&D expenditure by pharmaceutical companies.

Key Drivers, Restrains, and Opportunities of Global Pediatric Oncology Market

The main drivers of the growth of the global market for pediatric oncology treatments are the rise in cancer prevalence, the attractive reimbursement environment, and health care reforms. According to WHO statistics from 2018, cancer is the primary cause of death for kids and teenagers worldwide; each year, almost 300,000 kids between the ages of 3 and 19 are given a cancer diagnosis. Additionally, the WHO established the Global Initiative for Youth Cancers in 2018 with a number of partners to offer effective childhood cancer programmes around the globe.

WHO predicted that by the end of 2021, 4, 00,000 children and teenagers globally, aged 3 to 19 would receive a cancer diagnosis in each year. Additionally, in developed nations, there have been widespread introductions of programmes to raise awareness about pediatric cancer, and government investments to improve the pediatric healthcare system have increased. In turn, these variables will fuel market expansion in the ensuing years. The market is anticipated to grow quickly over the next years as more new medicines are released and more cutting-edge cancer treatments are created by pharmaceutical companies.

Global Pediatric Oncology Market: Segmentation

Based on indication, treatment, end-user, and location, the global market for pediatric oncology treatments can be divided. Leukaemia, bone tumours, brain malignancies, retinoblastoma, lymphoma, and other indications comprise the global market. The vast majority of childhood malignancies are leukaemia-related. Given that, it is the most prevalent cancer in children, the category is expected to dominate the market over the projection period. Chemotherapy, radiation, tumour surgery, and bone marrow transplantation are the different types of treatments available in the global pediatric oncology treatment market.

Growing public awareness of cancer treatment options, investment in R&D, and an increase in the prevalence of children cancers like neuroblastoma are all factors - driving market expansion. According to research conducted by the National Cancer Institute in February 2022, there will be one case of neuroblastoma for every 7000 infants. In Each year, 10.54 out of every 1,000,000 children under the age of 15 are diagnosed with this disease.

Global Pediatric Oncology Market- By Indication

• Leukaemia
• Bone Tumors
• Brain Cancers
• Retinoblastoma

Global Pediatric Oncology Market- By Treatment

• Chemotherapy
• Radiotherapy
• Tumor Surgery
• Blood & Marrow Transplantation

Global Pediatric Oncology Market- By End-user

• Hospitals
• Specialty Clinics
• Cancer & Radiation Therapy Centres

Pediatric Oncology Treatment Market: Competitive Landscape

Important Market Participants in the Pediatric Oncology Treatment Sector

The existence of a significant number of prominent competitors leads to expansion of the pediatric oncology treatments globally and therefore,  is extremely fragmented. The market for pediatric oncology treatments is projected to be driven by growth strategies used by major competitors.

The following companies are major players in the global market for paediatric oncology treatments:

• St. Jude Children's Research Hospitals, Royal Children's Hospital
• Birmingham Children's and Women's
• Child Health and Development National Center
• The St. Louis Children's Hospitals and the Vanderbilt University Medical Center
• Health SSM and other notable participants

Global Pediatric Oncology Market- By Region

• North America: U.S.A and Canada
• Europe: Germany, France, U.K., Italy
• Asia Pacific: China, Japan, India
• Latin America: Brazil, Mexico
• Middle East and Africa: South Africa, Rest of Middle East and Africa